A Phase 2 interventional study of Ibuprofen and placebo in Osteoarthritis, sponsored by BioChemics, Inc.. Completed at 5 sites in Switzerland. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2011-12-21.
Sponsored by BioChemics, Inc. · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 41 studies in Osteoarthritis with a site in Switzerland — 4 open to participants now, 15 under way, none of them phase 3. Osteoarthritis · Switzerland.
Among the 41 studies in Osteoarthritis with a site in Switzerland, this one is the 14th largest by enrollment of the 24 interventional ones that give a count, is one of 2 that started in 2011, is one of 3 in phase 2, and was the 9th registered.
2,975 studies on the registry are indexed under Osteoarthritis; 436 are open to participants now.
Browse Osteoarthritis studies →4 of the 41 studies in Osteoarthritis with a site in Switzerland are open now. Recruiting first, the newest first:
University Hospital, Basel, Switzerland · Sites in Switzerland, Austria, Croatia and 5 more countries
Ages 18–70
University Hospital, Basel, Switzerland · Sites in Switzerland, Croatia, Germany
Ages 18–65
University of Zurich · Sites in Switzerland
Ages 18+ · Healthy volunteers
Medacta International SA · Sites in Switzerland, Austria, Italy and 1 more country
Ages 18–75
A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →
Of the 285 Osteoarthritis studies recruiting now, 157 (55%) set no upper age limit and 71 (25%) stop at 75 or younger; 22 take children under 18; 30 take healthy volunteers.
This study: 40 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
41 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 4 · Phase 3 1 · Phase 4 4
First in 2003; this study’s year is marked. 2 started in 2011.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 75 is close to the median of 80 across 2,240 interventional studies indexed under Osteoarthritis.
Median enrollment 85 across the 24 interventional studies, 258 across the 16 observational. Of the 25 that completed or were terminated, 4 (16%) have results posted.
This tab as a report to print or save as PDF → With an account.
22 of 41 have an industry lead sponsor. The 10 most frequent:
BioChemics, Inc. is the lead sponsor of 2 studies on the registry; none are open to participants now.
BioChemics, Inc. has 1 study filed under Osteoarthritis — fewer than ten, so there is no comparison to draw.
2 of the studies in Osteoarthritis with a site in Switzerland that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03626038Zimmer BiometPost Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System | 2026-12 |
| NCT02038140Zimmer BiometZimmer Trabecular Metal Total Ankle PMCF | 2027-09 |
Add all 2 to your calendar (.ics) → With an account.
Among the 41 studies in Osteoarthritis with a site in Switzerland, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This is a phase 2a clinical trial performed to evaluate the efficacy of a topical treatment of ibuprofen compared to the use of a placebo topical treatment.
A multi-center, double-blinded, randomized placebo controlled study. Study length: 14 days Dosing twice daily (b.i.d.)
Main Inclusion Criteria:
Main Exclusion Criteria:
Drug: Ibuprofen
Drug: placebo
10% ibuprofen cream formulation at a dose of 200mg
2 grams of placebo cream for 14 days
Visual Analogue Scale (VAS) Pain scale
Time frame: 14 days
The record gives a start of Feb 2011, a primary completion of Aug 2011 and a completion of Aug 2011. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Ibuprofen
BioChemics, Inc.